Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study

被引：0
|
作者：
Yu, J. [1 ]
Wang, J. [2 ]
Sun, X. [1 ]
Wang, L. [3 ]
Ye, M. [4 ]
Feng, P. [5 ]
Zhu, G. [6 ]
Lu, Y. [7 ]
Zhu, S. [8 ]
Liao, Z. [9 ]
机构：
[1] Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China
[2] Zhengzhou Univ, Canc Hosp, Jinan 250117, Shandong, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Beijing 100730, Peoples R China
[4] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China
[5] Jiangsu Canc Hosp, Nanjing, Peoples R China
[6] Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
[7] Sichuan Univ, W China Hosp, W China Sch Med, Chengdu 610064, Peoples R China
[8] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S315 / S316
页数：2
相关论文
共 50 条
  • [21] Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial
    Jia, Ruinuo
    Shan, Tanyou
    Zheng, Anping
    Zhang, Yaowen
    Lu, Ping
    Zhang, Guifang
    Wang, Feng
    Xu, Zhiqiao
    Zheng, Guobao
    Tang, Dongxia
    Zhang, Weiguo
    Li, Wanying
    Li, Ruonan
    Guo, Yibo
    Liu, Lina
    Luo, Xiaoyong
    Zheng, Yingjuan
    Chang, Zhiwei
    Wang, Qiming
    Wang, Xinshuai
    Yuan, Xiaozhi
    Kong, Guoqiang
    Li, Shuoguo
    Yang, Ruina
    Zhou, Dan
    Ren, Jing
    Yin, Weijiao
    Li, Jingxia
    Zhang, Junqian
    Wang, Ziqi
    Sheng, Manxi
    Xu, Bingyi
    Li, Liuyan
    Liu, Xiaoyi
    Lu, Zhihao
    Wan, Lixin
    Zhou, Fuyou
    Gao, Shegan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (20) : 2436 - 2445
  • [22] Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: A phase II study
    Varghese, Sunitha Susan
    Ram, Thomas Samuel
    Pavamani, Simon Pradeep
    Thomas, Elsa Mary
    Jeyaseelan, Visalakshi
    Viswanathan, Peringulam Narayan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (02) : 330 - 336
  • [23] Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
    Jiang, Hui
    Li, Qiaoqiao
    Chen, Baoqing
    Xi, Mian
    Makelike, Kanjiebubi
    Liu, Shiliang
    Hu, Yonghong
    Zhu, Yujia
    CANCER MEDICINE, 2023, 12 (14): : 15187 - 15198
  • [24] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [25] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [26] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [27] PHASE-II STUDY TO EVALUATE THE TOXICITY AND EFFICACY OF CONCURRENT CISPLATIN AND RADIATION-THERAPY IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    PEARCEY, RG
    STUART, GCE
    MACLEAN, GD
    NATION, JG
    ARTHUR, K
    LUKKA, H
    JEFFREY, J
    JAMES, K
    BRUNDAGE, M
    GYNECOLOGIC ONCOLOGY, 1995, 58 (01) : 34 - 41
  • [28] A multicenter phase II trial of docetaxel, cisplatin and cetuximab (TPE) followed by cetuximab concurrent with radiotherapy in patients with local advanced squamous cell carcinoma of the head and neck (ECRIPS study).
    Zenda, Sadamoto
    Ota, Yosuke
    Kiyota, Naomi
    Okano, Susumu
    Fujii, Masato
    Kitamura, Morimasa
    Takahashi, Shunji
    Ueda, Tsutomu
    Monden, Nobuya
    Yamanaka, Takeharu
    Tahara, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Enokida, Tomohiro
    Ogawa, Takenori
    Homma, Akihiro
    Okami, Kenji
    Minami, Shujiro
    Nakanome, Ayako
    Shimizu, Yasushi
    Maki, Daisuke
    Ueda, Yuri
    Fujisawa, Takao
    Motegi, Atsushi
    Ohkoshi, Akira
    Taguchi, Jun
    Ebisumoto, Koji
    Nomura, Shogo
    Okano, Susumu
    Tahara, Makoto
    CANCER MEDICINE, 2020, 9 (05): : 1671 - 1682
  • [30] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study.
    Wang, Feng
    Qi, Yu
    Meng, Xiangrui
    Fan, Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345